EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical features and progression of Parkinson's disease with LRRK2 variants: A prospective study

Tingwei Song iD, Xiaoxia Zhou, Chunyu Wang, Heng Wu, Xinxiang Yan, Jifeng Guo, Beisha Tang iD, Lifang Lei iD, Qian Xu iD, Parkinson's Disease & Movement Disorders Multicenter Database and Collaborative Network in China (PD‐MDCNC)

Annals of Clinical and Translational Neurology · 2025

DOI: 10.1002/acn3.52244 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2025. Verfasst von Tingwei Song und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Parkinson Disease, Disease Progression. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Hunan Innovative Province Construction Project, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We established a prospective cohort study to investigate the differences in motor and non‐motor symptoms between idiopathic Parkinson's disease (IPD) and Parkinson's disease in carriers of leucine‐rich repeat kinase 2 (LRRK2) gene risk variants (LRRK2‐PD).

Methods

The study included 1407 individuals with IPD and 649 individuals with LRRK2‐PD (comprising 304 with LRRK2‐G2385R, 220 with LRRK2‐R1628P, and 105 with LRRK2‐A419V). Differences in symptoms between LRRK2‐PD and IPD were analyzed using LCMM modeling and Cox regression analysis.

Results

The LRRK2‐G2385R variant showed slower progression in tremor symptoms and excessive daytime sleepiness compared with IPD. In contrast, symptoms associated with LRRK2‐R1628P and LRRK2‐A419V were more similar to those of IPD. Survival analysis revealed that LRRK2‐PD does not affect life expectancy compared with IPD.

Interpretation

Our extended longitudinal follow‐up of LRRK2‐PD in the Chinese population provided valuable insights, further confirming the clinical characteristics of the three LRRK2 variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2Parkinson DiseaseDisease ProgressionHumansMaleFemaleMiddle AgedAgedProspective StudiesTremorLongitudinal Studies

Substanzen

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, human

Autor:innen und Institutionen

  • Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Nuclear Medicine, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Neurology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Neurology, The First Affiliated Hospital of University of South China, Hengyang, Hunan, China.
  • Key Laboratory of Hunan Province in Neurodegenerative Disorders, Changsha, Hunan, China.
  • National Clinical Research Centre for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.

ORCID-Profile: Tingwei Song, Beisha Tang, Lifang Lei, Qian Xu

Förderung

  • National Natural Science Foundation of China
  • Hunan Innovative Province Construction Project
  • National Key Research and Development Program of China

Zitieren

APA

Song, T., Zhou, X., Wang, C., Wu, H., Yan, X., Guo, J., Tang, B., Lei, L., Xu, Q., & Parkinson's Disease & Movement Disorders Multicenter Database and Collaborative Network in China (PD‐MDCNC) (2025). Clinical features and progression of Parkinson's disease with LRRK2 variants: A prospective study. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52244

Vancouver

Song T, Zhou X, Wang C, Wu H, Yan X, Guo J, et al. Clinical features and progression of Parkinson's disease with LRRK2 variants: A prospective study. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.52244

BibTeX
@article{Song2025,
  author = {Song, Tingwei and Zhou, Xiaoxia and Wang, Chunyu and Wu, Heng and Yan, Xinxiang and Guo, Jifeng and Tang, Beisha and Lei, Lifang and Xu, Qian and Parkinson's Disease & Movement Disorders Multicenter Database and Collaborative Network in China (PD‐MDCNC), Parkinson's Disease & Movement Disorders Multicenter Database and Collaborative Network in China (PD‐MDCNC)},
  title = {Clinical features and progression of Parkinson's disease with LRRK2 variants: A prospective study},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2025},
  doi = {10.1002/acn3.52244}
}
Kostenlos starten →